0000950123-23-004668.txt : 20230512 0000950123-23-004668.hdr.sgml : 20230512 20230512130237 ACCESSION NUMBER: 0000950123-23-004668 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 EFFECTIVENESS DATE: 20230512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioImpact Capital LLC CENTRAL INDEX KEY: 0001687078 IRS NUMBER: 364818254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-20107 FILM NUMBER: 23914497 BUSINESS ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: 399 BOYLSTON STREET, SUITE 1100 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: MPM Oncology Impact Management LP DATE OF NAME CHANGE: 20161007 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE 0001687078 XXXXXXXX 03-31-2023 03-31-2023 false BIOIMPACT CAPITAL LLC
399 BOYLSTON STREET, SUITE 1100 BOSTON MA 02116
13F HOLDINGS REPORT 028-20107 000309865 801-119133 N
Brendan Furey Chief Compliance Officer (617) 425-9222 /s/Brendan Furey Boston MA 05-12-2023 0 31 384916993 false
INFORMATION TABLE 2 23334.xml INFORMATION TABLE FOR FORM 13F Amicus Therapeutics Inc. Common 03152W109 4306158 388292 SH SOLE 388292 0 0 Arcutis Biotherapeutics inc Common 03969K108 2795507 254137 SH SOLE 254137 0 0 AVROBIO, Inc. Common 05455M100 647918 647918 SH SOLE 647918 0 0 Axsome Therapeutics, Inc. Common 05464T104 4342395 70402 SH SOLE 70402 0 0 Black Diamond Therapeutics, Inc. Common 09203E105 273838 144888 SH SOLE 144888 0 0 Chinook Therapeutics, Inc. Common 16961L106 4579209 197806 SH SOLE 197806 0 0 Crinetics Pharmaceuticals Inc. Common 22663K107 5787896 360392 SH SOLE 360392 0 0 Cullinan Oncology, Inc. Common 230031106 78241782 7648268 SH SOLE 7648268 0 0 Geron Corporation Common 374163103 18231396 8401565 SH SOLE 8401565 0 0 Harpoon Therapeutics, Inc. Common 41358P106 2378350 3196707 SH SOLE 3196707 0 0 Inhibrx, Inc Com Common 45720L107 22498342 1192281 SH SOLE 1192281 0 0 Inozyme Pharma Inc. Common 45790W108 1339261 233728 SH SOLE 233728 0 0 Insmed Incorporated Common 457669307 6806224 399192 SH SOLE 399192 0 0 Intellia Therapeutics, Inc. Common 45826J105 21335547 572459 SH SOLE 572459 0 0 Iovance Biotherapeutics Inc Com Common 462260100 15977509 2614977 SH SOLE 2614977 0 0 iTeos Therapeutics, Inc. Common 46565G104 23762284 1745943 SH SOLE 1745943 0 0 Iveric Bio Inc Common 46583P102 25441662 1045691 SH SOLE 1045691 0 0 Madrigal Pharmaceuticals inc Common 558868105 8730566 36038 SH SOLE 36038 0 0 Oncorus, Inc. Common 68236R103 817699 2377031 SH SOLE 2377031 0 0 Phathom Pharmaceuticals inc Common 71722W107 1518071 212615 SH SOLE 212615 0 0 Provention Bio Inc Common 74374N102 28288797 1173809 SH SOLE 1173809 0 0 Reata Pharmaceuticals inc-a Common 75615P103 16544794 176874 SH SOLE 176874 0 0 REGENXBIO Inc. Common 75901B107 11680159 617671 SH SOLE 617671 0 0 Relay Therapeutics Inc. Common 75943R102 20186192 1225634 SH SOLE 1225634 0 0 Repare Therapeutics, Inc. Common 760273102 16136114 1639849 SH SOLE 1639849 0 0 Revolution Medicines, Inc. Common 76155X100 5350497 247022 SH SOLE 247022 0 0 TCR2 Therapeutics, Inc. Common 87808K106 5056473 3370982 SH SOLE 3370982 0 0 Travere Therapeutics Inc. Common 89422G107 7053809 313642 SH SOLE 313642 0 0 Uniqure N.V. Common N90064101 7013231 348224 SH SOLE 348224 0 0 Verve Therapeutics, Inc Common 92539P101 11586484 803501 SH SOLE 803501 0 0 Werewolf Therapeutics, Inc. Common 95075A107 6208829 2388011 SH SOLE 2388011 0 0